Digestive and Liver Disease Unit, University La Sapienza, Endoscopy, Sant'Andrea Hospital, Rome, Italy.
Dis Colon Rectum. 2010 Feb;53(2):135-42. doi: 10.1007/DCR.0b013e3181c3be55.
The efficacy of surgery in the postendoscopic management of low-risk malignant polyps is unclear. Although interobserver variability in the histological diagnosis was shown, its importance is unknown. The purpose of this study was to guide future research on the optimal strategy for low-risk polyps with the use of value-of-information analysis.
A decision-analysis model was constructed comparing the strategies of referring or not referring (waiting) to surgery patients with low-risk polyps. Probabilistic sensitivity analysis was performed to explore the effect of uncertainty about the input parameters. Value-of-information analysis was used to estimate the expected benefit of future research that would eliminate the decision uncertainty.
The number of postendoscopic surgeries to prevent 1 cancer-related death was 208. The incremental cost-effectiveness ratio of surgery vs waiting strategy was $215,291/life-year gained, surgery being a suboptimal choice in the reference case analysis. Probabilistic sensitivity analysis demonstrated that surgery was the optimal choice in 61% of the simulated scenarios. Most of the decision uncertainty was related with the combination of histological inaccuracy, prevalence of residual disease, and surgical mortality. The expected societal monetary benefit of further research from the perspective of the United States was estimated to be $1 billion.
The small benefit and the relatively high costs associated with surgery argue against surgical referral for low-risk malignant polyps; however, when a suboptimal histopathological accuracy was simulated, surgery appeared to be the most cost-effective option, prompting the need for further research.
内镜下治疗低危恶性息肉后手术的疗效尚不清楚。尽管组织学诊断的观察者间变异性已得到证实,但其重要性尚不清楚。本研究旨在通过价值信息分析为低危息肉的最佳策略研究提供指导。
构建了一个决策分析模型,比较了低危息肉患者转介或不转介(等待)手术的策略。进行概率敏感性分析以探索输入参数不确定性的影响。价值信息分析用于估计消除决策不确定性的未来研究的预期收益。
预防 1 例癌症相关死亡所需的内镜下手术后数量为 208 例。手术与等待策略相比的增量成本效益比为 215291 美元/生命年获益,手术在参考案例分析中是次优选择。概率敏感性分析表明,在 61%的模拟场景中,手术是最优选择。大多数决策不确定性与组织学不准确性、残留疾病的患病率和手术死亡率的组合有关。从美国的角度来看,进一步研究的预期社会货币收益估计为 10 亿美元。
手术相关的小收益和较高成本不利于低危恶性息肉的手术转介;然而,当模拟出次优的组织病理学准确性时,手术似乎是最具成本效益的选择,这促使需要进一步研究。